Berobenatide research examines the molecular engineering enabling monthly-interval GLP-1 receptor agonism and its implications for receptor pharmacology.

Exploring eloralintide research as a selective amylin receptor agonist and how it compares mechanistically to dual amylin/calcitonin agents.

A non-steroidal SARM with partial agonist activity and high anabolic-to-androgenic ratio in preclinical studies — selectivity and binding kinetics.

A 29/30-amino-acid neuropeptide with roles in pain processing, appetite control, and adult neurogenesis — its three receptor subtypes as research...

How short peptide sequences spontaneously form nanofibers, hydrogels, and 3D scaffolds — applications in wound healing and regenerative research.